CORRECTION: Hemptown USA Launches First Consumer Product SKU: Hemptown Chew, a CBD & CBG-Infused Gum
30 sept. 2019 20h44 HE
|
Hemptown USA
CENTRAL POINT, Ore., Sept. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – This document corrects and replaces the announcement from Sept. 30, 2019, 8:00 a.m. ET. Hemptown USA, a multistate hemp...
Hemptown USA Launches First Consumer Product SKU: Hemptown Chew, a CBD & CBG-Infused Gum
30 sept. 2019 08h00 HE
|
Hemptown USA
CENTRAL POINT, Ore., Sept. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Hemptown USA, a multistate hemp operation and subsidiary of Hemptown Organics Corp., today unveiled its new Hemptown Chew...
Geocann is first-to-market introducing cannabigerol (CBG) formulations utilizing the VESIsorb® drug delivery system
23 août 2019 11h00 HE
|
Geocann
FORT COLLINS, Colo., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized the first cannabigerol (CBG) soft gel products that utilize the...
Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License
05 juin 2019 09h46 HE
|
Relevium Technologies Inc
MONTREAL, June 05, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned...
AXIM® Biotech Enters Services Agreement With CRO to Begin Clinical Studies On Dronabinol and CBD Chewing Gums
09 avr. 2019 09h35 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC:AXIM), a world leader in cannabinoid research and development, today...
New U.S. Patent Issuance Granted to AXIM® Biotechnologies for Oral Care Composition Containing Cannabinoids
29 janv. 2019 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the...
Relevium Engages PipeDreemz as Lead ACMPR Consultant for Biocannabix
17 mai 2018 08h00 HE
|
Relevium Technologies Inc
MONTREAL, May 17, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has engaged PipeDreemz as...
Relevium Creates Biocannabix Subsidiary and Targets Legal Cannabis Business
19 avr. 2018 10h14 HE
|
Relevium Technologies Inc
MONTREAL, April 19, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX VENTURE:RLV) (OTCQB:RLLVF) (FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce the creation of...
AXIM Biotechnologies Reports Second Quarter 2017 Results
22 août 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter...
Axim® Biotechnologies, Inc. Donates Flagship CanChew Gum to U.S. Pain Foundation to Help Chronic Pain Sufferers
22 nov. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Nov. 22, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has donated...